This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
This product is temporarily unavailable.
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
healthcareylife_pct_generic_price fishery1x1atomoxetine (60mg) is an atypical antipsychotic medication primarily used to treat some mental health disorders such as schizophrenia, bipolar disorder and major depressive disorder. It is also used to treat Attention Deficit Hyperactivity Disorder (ADHD), helping to increase alertness and alertness without negatively impacting on an individual's ability to perform daily tasks. Atomoxetine is an atypical antipsychotic drug that works by blocking dopamine and serotonin receptors, which are neurotransmitters in the brain. It is not known if Strattera works in the same way as other atypical medications, but it is believed to work by affecting the levels of these neurotransmitters in the brain.
atomoxetine (60mg) is also used to treat ADHD as part of a comprehensive treatment program that includes behavior, therapy and cognitive-behavioral therapy (CBT). Strattera is thought to work by increasing the levels of dopamine and serotonin in the brain, which are believed to play a role in developing ADHD symptoms. Strattera is also sometimes used as part of a comprehensive treatment program that includes antidepressant medication for depression as part of the treatment plan. The Food and Drug Administration (FDA) has not approved Strattera for the treatment of ADHD, but it is thought to work well for people with ADHD who are struggling with symptoms of ADHD. Strattera is usually taken orally once or twice daily with or without food.
Strattera comes in oral capsules and tablet form. The oral forms of Strattera are usually taken on an empty stomach, with or without food. Take Strattera at about the same time each day, even if you take it without regard to timing. Take Strattera at approximately the same time each day, with or without food. Do not take Strattera more than 1 time per day. Take Strattera only when prescribed by your doctor. The recommended dose of Strattera for adults is one capsule per day, with or without food. If you miss a dose, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double the dose to make up for a missed one.
Take Strattera at about the same time each day, with or without food. Do not take Strattera 30 minutes before breakfast.
Store Strattera at room temperature, out of reach of children. Keep it out of reach of children and out of the sight and reach of children. Do not store in long-term mailboxes.
br childcareDo not double the dose to make up for a missed dose.
INDICATIONS
Strattera is a selective non-amphetamine-reuptake inhibitor (SNRI) used for the treatment of attention deficit hyperactivity disorder (ADHD).
INSTRUCTIONS
Strattera is available in a generic form in the following strengths:
Use of Strattera is not recommended for patients with a history of seizures.
DOSAGE
The recommended dose is 50mg once daily or 20mg twice daily. The maximum daily dose is 150mg. It may be increased to a maximum of 400mg, and may be gradually lowered, depending on the response of the patient.
STORAGE
Store Strattera at room temperature, away from light and moisture.
MORE INFO:Strattera comes in 50mg, 100mg, and 150mg strengths. If you have questions about the same strengths or the differences, talk to your doctor.
Strattera is not addictive.CHILDREN
Strattera may be prescribed for children aged 1 year and older.
STORAGE WARNINGS
The most common side effects of Strattera are drowsiness, nausea, and vomiting. Serious side effects are rare. Your doctor will decide if you need further monitoring.
STORAGE DISEASE WARNINGS
Children older than 2 years may be at risk of developing certain side effects. The risk is increased if they have had a history of seizures, or if they are taking a medicine called methylphenidate. In this case, your doctor may recommend the use of Strattera in children 1 month and older.
ADDING INFORMATION
The information provided below is provided in full with each drug and drug information. This information does not constitute medical advice. If you think any medical condition is causing your symptoms, ask your doctor or pharmacist.
If you are pregnant, think you may be pregnant, or are breastfeeding, or you suspect you may be pregnant, ask your doctor for advice before taking Strattera.
The information provided does not replace the advice of your physician. If you are a woman who is pregnant or breastfeeding, talk to your doctor or pharmacist before taking Strattera.
CONTRAINDICATION
Strattera may be contraindicated in the following conditions:
ADHD
ADHD (hypomania) has not been evaluated
ADHD has been associated with a small increase in risk of suicide attempts
Strattera can cause side effects (including drowsiness, nausea, and headache) in some people. These side effects may be temporary or permanent.
Strattera should not be used if you have a seizure disorder or a family history of seizures. Your doctor will discuss with you the possible risks and benefits of taking Strattera.
Tell your doctor or pharmacist if you have any of the following medical conditions:
ADHD (hypomanic episodes)
ADHD has not been evaluated
If you are taking this medicine, tell your doctor or pharmacist of all the medicines you are taking. This includes medicines used to treat anxiety, depression, obsessive-compulsive disorder, panic disorder, anxiety disorders, bulimia, and premenstrual dysphoric disorder.
This includes medicines used to treat depression, such as phenytoin, tricyclic antidepressants, and monoamine oxidase inhibitors.
Strattera, also known as atomoxetine, is a non-stimulant medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). It was first approved by the FDA in 2002 and has been a significant revenue generator for Eli Lilly.
One of the most critical factors for patent expiry for Strattera is the expiry of its generics competition. When a drug is widely available, patients may unknowingly unknowingly opt for generic versions of its active ingredient, which can be expensive and not be priced based on effectiveness.
Generics companies are reiterating theirstronger incentives for marketing and sales of their pharmaceuticals despite the entry ofgeneric versions of theirbrand generics.
The FDA's recent ruling mandates that generics companies stop marketing their chemical entity and instead submit new pharmaceuticals to the FDA.
Generic versions of the brand name medication Strattera have faced major generic competition from Eli Lilly and Emery Pharmaceuticals in the last few years. Generic versions of Strattera are also on the market, and generic versions of the brand name medication,, have already faced significant competition.
Strattera has faced several major generic competition from Eli Lilly and Emery in the last few years, each of which has faced significant competition from Novartis, Bristol-Myers Squibb, Teva Pharmaceuticals, and SmithKline Beavoord.
Strattera has faced several major generic competition from Eli Lilly and Emery in the U. S., each of which has faced significant competition from Novartis, Bristol-Myers Squibb, Teva Pharmaceuticals, and SmithKline Beavoord.
Strattera has faced several major generic competition from Eli Lilly and Emery in Europe, each of which has faced significant competition from Novartis, Bristol-Myers Squibb, Teva Pharmaceuticals, and SmithKline Beavoord.
Strattera has faced several major generic competition from Eli Lilly and Emery in Australia, each of which has faced significant competition from Novartis, Bristol-Myers Squibb, Teva Pharmaceuticals, and SmithKline Beavoord.
Strattera has also faced several major generic competition from Eli Lilly and Emery in Australia, each of which has faced significant competition from Novartis, Bristol-Myers Squibb, Teva Pharmaceuticals, and SmithKline Beavoord.
Strattera has faced several major generic competition from Eli Lilly and Emery in Japan, each of which has faced significant competition from Novartis, Bristol-Myers Squibb, Teva Pharmaceuticals, and SmithKline Beavoord.
Strattera has also faced several major generic competition from Eli Lilly and Emery in Japan, each of which has faced significant competition from Novartis, Bristol-Myers Squibb, Teva Pharmaceuticals, and SmithKline Beavoord.
As of 2019, the global market for Strattera is estimated at USD 14.5 billion, with significant competition from generics making up around $30 billion.
Eli Lilly and Lilly's pharmaceuticals division has faced significant generic competition from Eli Lilly and Emery in the U. S., which is currently the biggest revenue generator for Eli Lilly and Emery.
Eli Lilly and Emery's pharmaceuticals division has faced significant generic competition from Eli Lilly and Emery in the U. S.
Strattera (atomoxetine) is a selective norepinephrine reuptake inhibitor (NRI) that belongs to a class of medications called a selective norepinephrine reuptake inhibitor (SNRI).
The NRI is used to treat narcolepsy, attention deficit hyperactivity disorder (ADHD), and other conditions that interfere with focus and judgment, such as attention deficit hyperactivity disorder (ADHD).
Strattera may also be used for other purposes not listed in this medication guide.
This guide is intended to be a general guide to the use of atomoxetine in children and adults, but it should not refer to it in any way unless it is stated in the guide or shown to be so. It should not be considered medical advice unless it is stated in the guide or shown to be so.
The information in this guide is for general information purposes only. It may not be exhaustive. If you have any questions about this medication, ask your doctor or pharmacist before use it for any purpose other than what is stated in this guide.
It is an antidepressant medication that is used to treat a variety of mental and mood disorders. It works by affecting the levels of certain neurotransmitters in the brain.
Strattera is sometimes called the “typical” antidepressant. It is the first-line therapy in some cases, as well as a treatment for ADHD. Strattera is not a stimulant medication, but rather is a norepinephrine reuptake inhibitor (NRI) that may be used to treat depression.
Strattera helps to regulate the levels of certain chemicals in the brain, called neurotransmitters. The goal of treatment is to increase the function of these chemicals in the brain. Strattera helps to increase levels of the neurotransmitters in the brain, called norepinephrine, and, in some cases, to improve the symptoms of ADHD.
₨25, mgOriginal price was: ₨ 25, mg. We can save you money on all our prices.
Strattera is an antidepressant drug used to treat attention-deficit hyperactivity disorder (ADHD) and narcolepsy. It belongs to the class of drugs called selective norepinephrine reuptake inhibitors.
Strattera is also used to treat attention-deficit/hyperactivity disorder (ADHD) in adults and children.
The usual starting dose of Strattera is one tablet (atomoxetine) three times a day. The maximum dose may be one tablet (50 mg) three times a day.
For children, the dose can be increased to 100 mg or decreased to 25 mg based on your child’s condition. For adults, the dose can be decreased to 25 mg based on your child’s response to the treatment.
Your doctor will decide the right dosage based on your child’s weight and the severity of their condition.
If your child’s condition persists or worsens, your doctor may increase the dosage to 25 mg or decrease to 25 mg based on their response.
Stade de France Pharmacy